Abstract

Abstract:

The present disclosure relates to process for the preparation of (2R,4S) -4- {[3,5 bis (trifluoro methyl) benzyl]-[5-(3-carboxy propoxy) pyrimidin-2-yl] amino}-2- ethyl-6-trifluoro methyl-3,4- dihydro-2H- quinolone -1-carboxylic acid ethyl ester, represented by structural formula-1 or its pharmaceutically acceptable salts and its intermediate compounds.

Formula-1

The present disclosure also relates to the novel intermediate compounds that are used in the preparation of formula-1

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS